Lipoprotein apheresis, a therapy normally used to filter excess cholesterol from the blood of patients with familial hypercholesterolemia, may have a new role in patients with refractory angina. New ...

The rebound in plasma cholesterol that occurs following plasma exchange or Lp apheresis is illustrated in Figure 1. The extent of the immediate decrease depends upon the efficiency of the system used ...

Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a developer of dialysis-like therapies to address cardiovascular disease and cancer, today released a note authored by inventor and ...

HDL was reduced from 1.0 ± 0.2 mmol/L pre- to 0.5 ± 0.1 mmol/L post-apheresis (p = 0.03). It increased following apheresis and then remained constant throughout the evolocumab treatment. Lp(a) ...

LAS VEGAS — Lipid apheresis can significantly reduce lipoprotein(a) levels compared with available drug therapies, according to a presentation at National Lipid Association Scientific Sessions.

Drs Brinton and Michos highlight LDL-C apheresis in the treatment landscape for homozygous familial hypercholesterolemia [HoFH]. Eliot Brinton, MD: What do we do if the standard treatments don’t work?

Familial hypercholesterolemia is an autosomal dominant disorder resulting in severe elevation of total and LDL cholesterol due to defective hepatic LDL receptor. Heterozygotes occur in about 1 of 500 ...

Lipoprotein apheresis, a therapy normally used to filter excess cholesterol from the blood of patients with familial hypercholesterolemia, may have a new role in patients with refractory angina.

Subhash Banerjee, MD (VA North Texas Health Care System & UT Southwestern Medical Center, Dallas), who presented the results of the PREMIER trial in a featured clinical research session at the annual ...

In a longer and larger observational study of German patients, followed up for 1–31 years, mortality was 43% among the seven untreated homozygotes compared with 21% in the 14 who were treated with Lp ...

Rome, Italy – 29 August, 2016: Lipoprotein apheresis, a therapy normally used to filter excess cholesterol from the blood of patients with familial hypercholesterolemia, may have a new role in ...

Cholesterol bloodstream An undesirable lipoprotein effect of LDL apheresis is the lowering of high-density lipoprotein (HDL) cholesterol. Proprotein convertase subtilisin/kexin type 9 (PCSK9) ...